ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
GeNeuro SA

GeNeuro SA (GNRO)

0.215
-1.54
(-87.75%)
Closed June 28 10:30AM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.215
Bid
0.187
Ask
0.248
Volume
1,052,864
0.152 Day's Range 0.45
0.152 52 Week Range 2.35
Market Cap
Previous Close
1.755
Open
0.152
Last Trade
4000
@
0.215
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
12,747
Shares Outstanding
29,760,933
Dividend Yield
-
PE Ratio
-
Earnings Per Share (EPS)
-
Revenue
-
Net Profit
-

About GeNeuro SA

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Geneva, Che
Founded
1970
GeNeuro SA is listed in the Pharmaceutical Preparations sector of the Euronext with ticker GNRO. The last closing price for GeNeuro was 1.76 €. Over the last year, GeNeuro shares have traded in a share price range of 0.152 € to 2.35 €.

GeNeuro currently has 29,760,933 shares outstanding.

GNRO Latest News

GeNeuro Announces Results of the GNC-501 Study in Post-Covid-19 Syndrome

Regulatory News: GeNeuro (Euronext Paris: CH0308403085 – GNRO): The GNC-501 clinical trial is a Phase 2 study in patients suffering from post-COVID-19 neuropsychiatric syndromes, testing...

Les actionnaires de GeNeuro approuvent l’ensemble des résolutions proposées à l’Assemblée Générale Annuelle 2024

81,54% du capital social de la société était représenté à l'assemblée générale et les résolutions ont toutes été approuvées à l’unanimité Regulatory News: GeNeuro (Euronext Paris : CH0308403085...

Modalités de mise à disposition des informations relatives à l’assemblée générale des actionnaires du 12 juin 2024

Regulatory News : GeNeuro (Euronext Paris : CH0308403085 - GNRO), société biopharmaceutique développant de nouveaux traitements pour les maladies neurodégénératives et auto-immunes, telles que la...

GeNeuro Announces Last Patient Last Visit in its Post-COVID Trial and Confirms Top-Line Results by End of June 2024

The GNC-501 study against Post-Covid completed the last patient visit The study’s objective is to evaluate the efficacy and safety of temelimab on the improvement of fatigue and cognitive...

GeNeuro Publishes its 2024 Universal Registration Document

Regulatory News: GeNeuro (Euronext Paris: CH0308403085 – GNRO), a biopharmaceutical company developing novel treatments for neurodegenerative and autoimmune diseases such as multiple sclerosis...

GeNeuro annonce ses résultats annuels 2023 et fait le point sur ses développements

Essai clinique de phase 2 avec temelimab dans les syndromes neuropsychiatriques Post-COVID (GNC-501) : Recrutement achevé en novembre 2023 ; Résultats préliminaires attendus pour fin juin 2024...

Les actionnaires de GeNeuro approuvent l’ensemble des résolutions proposées à l’Assemblée Générale Extraordinaire du 18 mars 2024

81,4% du capital social de la société était représenté à l'assemblée générale et les résolutions ont toutes été approuvées à l’unanimité Regulatory News: GeNeuro (Euronext Paris : CH0308403085 –...

GeNeuro annonce la mise à disposition d’un prospectus à l’occasion de l’admission d’actions nouvelles sur Euronext Paris

Le présent communiqué n’est pas une communication à caractère promotionnel et ne constitue pas un prospectus au sens du Règlement (UE) 2017/1129 Regulatory News: NE PAS PUBLIER, DISTRIBUER OU...

Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
1-1.385-86.56251.61.990.152124511.7948613DE
4-1.685-88.68421052631.92.350.152152471.9173872DE
12-1.205-84.85915492961.422.350.152127471.81532101DE
26-0.85-79.81220657281.0652.350.152103421.5813298DE
52-1.48-87.31563421831.6952.350.15281801.49840698DE
156-3.445-94.12568306013.664.390.15259832.31028784DE
260-3.625-94.40104166673.846.280.15260102.94767556DE

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
DNDelta 9 Cannabis Inc
$ 0.015
(50.00%)
1.1M
BRMIBoat Rocker Media Inc
$ 1.02
(29.11%)
1.84M
TSATTelesat Corporation
$ 12.50
(17.26%)
3.24k
QECQuesterre Energy Corporation
$ 0.25
(16.28%)
24.6k
GEOGeodrill Limited
$ 2.30
(15.58%)
47.28k
NCPNickel Creek Platinum Corp
$ 0.01
(-33.33%)
1.07k
LPENLoop Energy Inc
$ 0.025
(-28.57%)
73.62k
ASNDAscendant Resources Inc
$ 0.035
(-22.22%)
1,000
FLNTFlint Corporation
$ 0.025
(-16.67%)
16.5k
BNGBengal Energy Ltd
$ 0.03
(-14.29%)
85k
TRPTC Energy Corporation
$ 51.87
(-1.76%)
34.35M
BNSBank of Nova Scotia
$ 62.58
(0.29%)
18.9M
POWPower Corp of Canada
$ 38.02
(-1.66%)
13.19M
TDToronto Dominion Bank
$ 75.20
(0.09%)
9.87M
MFCManulife Financial Corporation
$ 36.44
(0.41%)
6.48M

Discussion

View Full Feed
WhAtEvA1 WhAtEvA1 4 minutes ago
LOL, at least now you can finally be yourself versus the initial efforts at "disguising" your cover. The game is on now and we'll see which side comes out triumphant. Go Vivos!
RDGL
Dalmatian Dalmatian 4 minutes ago
Has already been deleted once. May they thought I was talking about Chevron the stock…
NAK
SSKILLZ1 SSKILLZ1 4 minutes ago
SSKMP Managed Index (6/28/24 Update)

Commentary: The SSKMP Managed Index is Up 478.94% (+342.92% Including Options) Overall. And Up +1.55% YTD. The Cash Position so far has averaged 54.27% YTD.
[pre]
Symbol # Of Shares PP CP Value % Up/Down
$CASH$ $136,
ABBV AMPG AMRK
RedShoulder RedShoulder 4 minutes ago
Final After Hours high volume: 1,492,499

https://www.nasdaq.com/market-activity/stocks/avxl/after-hours
AVXL
hd3500 hd3500 5 minutes ago
What's the targets???
UBQU
highlandernew highlandernew 5 minutes ago
🔴🔴AMC is DWARFING Bitcoin multiplicator at 12.8x?:

*** Watch out when FOMO hits?! ***

*** One just needs to AVERAGE DOWN and be PATIENT enough? ***
&
AMC
classics99 classics99 5 minutes ago
And the 18-24 months is only a timeline for the phase 1 portion of clinical trials.
RDGL
Uncle Monkey Uncle Monkey 6 minutes ago
soooooooo last chance under $1?

hahaha, yeah ok!
ECSL
classics99 classics99 6 minutes ago
It unlikely you will see $0.15 shares as we have built a floor around the $0.18 to 0.21 level.

I would simply accumulate in the next few weeks instead of trying to get the best price.

Every long on this board and many others will be scooping up any cheap share we can a
RDGL
blackhawks blackhawks 6 minutes ago
There are very rarely permanent bans on this board, in stark contrast to the RW moron boards you frequent.
hd3500 hd3500 6 minutes ago
Good question. Let me know if anyone answers. I also want to know what 99 means.
DPLS
Uncle Monkey Uncle Monkey 6 minutes ago
this great news and NO buyers.. SAD
ECSL
4OurRetirement 4OurRetirement 6 minutes ago
Looks Like No RussellFund Shares Posted In AfterHours…

That Doesn’t Explain Last Friday’s 4 Million Shares That Traded After Close. Were Those Related To Russell Rebalancing?

If Not, What Might Explain Last Friday’s High Volume?

Oh Well. Enjoy Your Weeken
CDMO
delerious1 delerious1 7 minutes ago
If Biden withdrew who would and could do the best job and beat derTrumpfh ?
Uncle Monkey Uncle Monkey 7 minutes ago
another down day
ECSL
dealerschool2006 dealerschool2006 7 minutes ago
#natgas going into over sold territory...bottom next week maybe...$BOIL options are calling me...
BOIL
GBR GBR 7 minutes ago
When you compare the May earnings call with the Nov. 2023 earnings call, there has obviously been a delay in the integration of Broadbean.

Also last year RS said something to the effect that the "beginning" of 2024 will be an inflection point in our growth trajectory. They said growt
VERI
STILL TOWING STILL TOWING 8 minutes ago
I know where he is/ was too... Lol.. So ironic. Explains all the irrational posts..I love it
MRGE
Aquahoya Aquahoya 9 minutes ago
Going to grab some more under .10 before it goes. Whoever is flipping may have to buy above .10 now.
BMXI
fuagf fuagf 9 minutes ago
Jon Stewart's Debate Analysis: Trump's Blatant Lies and Biden's Senior Moments | The Daily Show

[yt]3SJr44m-w1Y[/yt]
The Daily Show

Jun 28, 2024 #DailyShow #JonStewart #Debate
Jon Stewart goes live after CNN's presidential debate to unpack Biden's senior
kayak_wench kayak_wench 9 minutes ago
Here is summary from ChatGPT. Several here (myself included) figured this out the hard way (read FDA documents) a few years back when they submitted their first attempt at an IDE. It is correct as my memory serves. Heads up Vivos expects to get a class II designation. Initial feedback from FDA po
RDGL
LuLa LuLa 10 minutes ago
$CYBL Attorney Letter

https://x.com/CyberluxC/status/1806839783076843734
CYBL
MightyX MightyX 10 minutes ago
Traders have to Jack-up price to turn profit
TPTW